Cornes, 3M Ventures and Repsol Energy Ventures contributed to a round that increased the in-mold structural electronics provider's total funding to more than $59m.

The tissue analysis technology developer has now raised more than $37m, having received $23.6m in a first tranche of its series C round that was led by PHC Holdings.

The personalised therapy management platform closed a round led by Cardinal Health with backing from Novartis and Kite Pharma, taking its overall funding to more than $82m.

Dell Technologies Capital and Qualcomm Ventures both invested in a $21.5m round that will fund growth of FloLive's internet-of-things managment platform.

EPFL-founded tissue analysis technology developer Lunaphore has now raised $37.3m in all after a series C round led by medical products firm PHC Holdings.

Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.

Azafaros, a metabolic disorder drug developer leveraging Leiden University and Amsterdam UMC inventions, has secured $28m in series A capital.

Existing investor Gradient Ventures invested in a series B round that almost doubled the clinical research software provider's overall funding to $45m.

The Mastercard-backed customer service bot developer took its total funding past $50m with $7m from Napier Park Financial Partners.

The Visa-backed enterprise payment software producer will use the series B funds for hiring, product development and international growth.